Insights
Enhancing Diversity in Clinical Trials for Better Health Outcomes
Diversity in clinical trials is essential for ensuring that medical research reflects the needs of all communities. This means including participants from different races, ethnicities, and backgrounds.
Increasing Patient Engagement in Clinical Trials: A Guide for Biotech and Pharma Teams
When patients feel included, they are more likely to contribute valuable insights that can shape research outcomes and improve the overall process.
Small Pharma Clinical Trial Cost Management: Strategies for Effective Drug Development and Budgeting
Whether you are a small firm or an established player, knowing how to streamline processes will enhance your ability to conduct effective clinical trials.
Cardiovascular Diversity Enrollment Case Study
How TOTAL Diversity exceeded the diversity target by 27% and completed the study three weeks early by prioritizing sites with access to Fitzpatrick V and VI participants.
Implementation and Evaluation of a Self-Paced Diversity Training and Education (DTEACH©)Pilot Program for Clinical Trials Site Participant
How the DTEACH© pilot program boosted diversity in neurology clinical trials, with impressive results like an 84.27/100 satisfaction rating and improved recruitment practices across 40 U.S. sites.
TOTAL Diversity Blog
On June 26, 2024, the FDA released draft guidance on the Food and Drug Omnibus Reform Act (FDORA), setting new expectations for inclusivity in pivotal studies.
Get Connected with the TOTAL Team
Phone
(214) 855-1222
The Only CRO with Comprehensive Diversity Integration Services
